Management of membranous nephropathy

Minerva Urologica e Nefrologica

Volumn 54, Issue 1, 2002, Pages 19-27

  Cattran, D C ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Glomerulonephritis, membranous, diagnosis; Glomerulonephritis, membranous, drug therapy; Immunosuppressive agents

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CHLORAMBUCIL; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PLACEBO;

ANTIBODY RESPONSE; BLOOD PRESSURE REGULATION; DIETARY INTAKE; DRUG EFFECT; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYPERCOAGULABILITY; HYPERLIPIDEMIA; IDIOPATHIC DISEASE; MEMBRANOUS GLOMERULONEPHRITIS; PROGNOSIS; PROTEIN RESTRICTION; PROTEINURIA; REVIEW; PATHOPHYSIOLOGY; RISK FACTOR;

GLOMERULONEPHRITIS, MEMBRANOUS; HUMAN; RISK FACTORS; HUMANS;

EID: 0036013411     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997
2. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study
3. Glomerulopathies associated with parasitoses
4. The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis
5. Membranous glomerulonephritis and malignancy
6. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis)
7. Role of C5b-9 in experimental membranous nephropathy
8. Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy
9. Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan
10. Idiopathic membranous nephropathy in identical twins
11. An analysis of HLA class II gene polymorphism in British and Greek idiopathic membranous nephropathy patients
12. Predicting progression in membranous glomerulonephritis
13. A review of therapeutic studies of idiopathic membranous glomerulopathy
14. Epidemiology of primary glomerular diseases in a French region. Variations according to period and age
15. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy
16. Natural history, clinical course and morphological evolution of membranous nephropathy
17. Idiopathic membranous nephropathy: The natural history of untreated patients
18. Remissions and relapses in idiopathic membranous nephropathy
19. Long-term outcome of idiopathic membranous nephropathy with nephrotic syndrome
20. Prognosis of untreated patients with idiopathic membranous nephropathy
21. Tubulointerstitial lesions in human membranous glomerulonephritis: Relationship to proteinuria
22. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis
23. Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications
24. Survival in idiopayhic membranous glomerulonephritis
25. A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome
26. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy
27. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
28. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy
29. Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial
30. A controlled trial of cyclosporine in patients with progressive membranous nephropathy
31. Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function
32. Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure
33. Immunosuppression and outcome in idiopathic membranous nephropathy
34. Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone
35. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults
36. Methylprednisolone in patients with membranous nephropathy and declining renal function
37. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study
38. Antiproteinuric effect of blood-pressure-lowering agents: A meta-analysis of comparative trials
39. Lipid abnormalities in the nephrotic syndrome: Causes, consequences, and treatment
40. Treatment of hyperlipidemia in the nephrotic syndrome: The effects of pravastatin therapy
41. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease
42. Idiopathic membranous nephropathy in an Australian population: The incidence of thromboembolism and its impact on the natural history
43. Thrombosis and hemostasis in renal disease
44. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
45. Pneumocystis carinii pneumonia: A major complication of immunosuppressive therapy in patients with Wegener's granulomatosis